Weekly Dulaglutide Performs Well in Comparison to Daily Liraglutide

| Aug 1, 2014

A comparison of the effects on A1c between users of once-weekly dulaglutide (made by Eli Lilly and Company) and once-daily liraglutide (sold as Victoza from Novo Nordisk) shows that both drugs have very similar effects.

Researchers at Ohio State University conducted a nine-country study of 599 type 2 patients, aged 18 years and older, with A1c's between 7% and 10%, and taking at least 1,500 mg of metformin daily. The patients were split into two groups, with 299 receiving dulaglutide and 300 receiving liraglutide.

After 30 weeks, the mean reduction in A1c was -1.4% in the dulaglutide group versus -1.36% in the liraglutide group—a statistically insignificant difference. Other differences between the two groups were also statistically negligible: 20 percent of the dulaglutide group experienced nausea, compared with 18 percent in the liraglutide group; 12 percent of participants in both groups reported diarrhea, and 7 percent of the dulaglutide patients experienced vomiting versus 6 percent in the liraglutide group. Six percent of the participants in both groups dropped out of the study along the way due to drugs' side effects.

None of the patients experienced severe hypoglycemia. For dulaglutide patients, the rate of hypoglycemic episodes per year was 0.34 and for liraglutide patients, 0.52.

Click Here To View Or Post Comments

Categories: A1C, Diabetes, Diabetes Health, Diabetes Health Magazine, diabetes medical trials, diabetes medical trials, diabetes medicine, Dulaglutide, eli lily and company, eli lily and company, Hypoglycemia, Liraglutide, Living with Diabetes, Novo Nordisk, Victoza


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Aug 1, 2014

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.